Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 OctoPlus Signs CR Deal | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

OctoPlus Signs CR Deal

Drug delivery pact with unnamed U.S. partner

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

OctoPlus N.V. has signed a feasibility agreement with a U.S.-based pharmaceutical company relating to the use of OctoPlus’ controlled release technology. OctoPlus will develop a controlled release formulation of an undisclosed compound using its proprietary drug delivery technology PolyActive®.

If the evaluation is successful, the companies may decide to enter into a full process development, manufacturing and licensing agreement. Financial terms of the current agreement are not disclosed.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics